Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir strategies in lamivudine-resistant chronic hepatitis B
NCT00410202Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started Mar 2008; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00410202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410202.